1.Electrophysiology of Hypothalamic Neuroendocrine Cells.
Pan Dong RYU ; Seong Kyu HAN ; Kyung Yoon KAM ; Wonee CHONG
Journal of Korean Society of Endocrinology 2000;15(6):672-683
No Abstract Available.
Electrophysiology*
;
Neuroendocrine Cells*
2.Regulation of Estrogen Receptor mRNA in Rat Anterior Pituitary Gland.
Min Seok CHUN ; Duck Bae PARK ; Yong Bin PARK ; Kyung Yoon KAM ; Chang Mi KIM ; Kyung Ja YOO
Journal of Korean Society of Endocrinology 1997;12(4):518-527
The estrogen receptor (ER) is present in a wide variety of mammalian tissues and is required for the physiological responses of estrogen, including estrogen-induced tissue-specific changes in gene expression. But most of our knowledge on the regulation of ER mRNA levels comes from in vivo steroid replacement experiments or cancer cell lines that express the ER. Thus the present study was attempted to determine 1) the anterior pituitary ER mRNA levels during rat estrous cycle 2) if estradiol itself directly modulates the ER mRNA levels in cultured rat anterior pituitary using RT-PCR method. In rats with 4 day estrous cycle, the ER mRNA levels in anterior pituitary gland reached to maximum at proestrus 11:00h just before serum estradiol concentration showed the highest. From then, the ER mRNA levels gradually declined during the rest of the proestrus. On the other hands, in cultured rat anterior pituitary cells, the ER mRNA levels were significantly decreased by the treatment of estradiol. These results indicate that the surge of estradiol was proceeded by the increase in pituitary ER mRNA levels during the proestrus and in cultured anterior pituitary cells, estrogen might be involved in the down-regulation of the ER mRNA levels.
Animals
;
Cell Line
;
Down-Regulation
;
Estradiol
;
Estrogens*
;
Estrous Cycle
;
Gene Expression
;
Hand
;
Pituitary Gland, Anterior*
;
Proestrus
;
Rats*
;
RNA, Messenger*
3.Regulation of FSH Gene Expression and Release in Cultured Rat Anterior Pituitary Cells.
Min Seok CHEON ; Deok Bae PARK ; Yong Bin PARK ; Kyung Yoon KAM ; Kyung Za RYU
Journal of Korean Society of Endocrinology 2000;15(2):179-189
BACKGROUND: FSH is a heterodimeric glycoprotein and is composed of alpha and beta subunits. alpha subunit is common to FSH and LH, while an unique beta subunit determines the biological specificity of each hormone. The synthesis of beta subunit is the primary rate-limiting step in the synthesis of each hormone. Although FSH plays a pivotal role in folliculogenesis and ovulation, very little studies have been performed on the regulation of FSH beta gene expression. Therefore, the present study attempted to examine the effect of GnRH or activin on the expression of FSH beta mRNA as well as FSH release and signaling pathway involved in their actions. METHODS: The primary cultures of rat anterior pituitary were used for this study. To determine FSH beta mRNA levels, northern blotting method was used. The concentration of FSH in the culture medium was evaluated by using a specific radioimmunoassay for rat FSH. RESULTS: PMA, an activator of PKC, increased FSH beta mRNA levels and FSH release, whereas forskolin, an activator of adenylate cyclase, showed no effect. The application of GnRH augmented FSH release, but not FSH beta mRNA levels. However, the administration of activin increased FSH beta mRNA levels as well as FSH release. Staurosporine, an inhibitor of PKC, suppressed activin-induced increment of FSH beta mRNA levels and FSH release. CONCLUSION: The present study demonstrated that activin rather than GnRH is a major regulator for FSH beta mRNA expression, and suggest that PKC-dependent pathway is also involved in the action of activin on the expression of FSH beta mRNA and FSH release.
Activins
;
Adenylyl Cyclases
;
Animals
;
Blotting, Northern
;
Colforsin
;
Female
;
Follicle Stimulating Hormone
;
Follicle Stimulating Hormone, beta Subunit
;
Gene Expression*
;
Glycoproteins
;
Gonadotropin-Releasing Hormone
;
Ovulation
;
Radioimmunoassay
;
Rats*
;
RNA, Messenger
;
Sensitivity and Specificity
;
Staurosporine
4.Influence of GnRH Agonist and Neural Antagonists on Stress-blockade of LH and Prolactin Surges Induced by 17 beta-estradiol in Ovariectomized Rats.
Kyung Yoon KAM ; Yong Bin PARK ; Min Seok CHEON ; Sang Soo KANG ; Kyungjin KIM ; Kyungza RYU
Yonsei Medical Journal 2002;43(4):482-490
In our previous study, we demonstrated that immobilization stress blocked estrogen-induced luteinizing hormone(LH) surge possibly by inhibiting the synthesis and release of gonadotropin-releasing hormone (GnRH) at the hypothalamic level and by blocking estrogen-induced prolactin (PRL) surge by increasing the synthesis of dopamine receptor at the pituitary level in ovariectomized rats. The present study was performed to determine whether immobilization stress affects pituitary LH responsiveness to GnRH, and whether endogenous opioid peptide (EOP) and dopamine systems are involved in blocking LH and PRL surges during immobilization stress. Immobilization stress was found to inhibit basal LH release and to completely abolish LH surge. However, the intravenous application of GnRH agonist completely restored immobilization-blocked LH surge and basal LH release. Treatment with naloxone did not exert any effect on immobilization-blocked LH surge but increased basal LH release during immobilization stress. Pimozide did not affect immobilization-blocked LH surge or basal LH release. Naloxone also decreased immobilization-induced basal PRL release, but had no effect on immobilization-blocked PRL surge. Immobilization-increased basal PRL levels were augmented by pimozide treatment and immobilization-blocked PRL surge was dramatically restored by pimozide. We conclude that immobilization stress does not impair pituitary LH response to GnRH, and that the immobilization stress-induced blockage of LH surge is probably not mediated by either the opioidergic or the dopaminergic system. However, immobilization-blockade of PRL surge may be partly mediated by the dopaminergic system.
Animal
;
Estradiol/*pharmacology
;
Female
;
Gonadorelin/*pharmacology
;
Immobilization
;
Luteinizing Hormone/*secretion
;
Naloxone/pharmacology
;
Opioid Peptides/physiology
;
Ovariectomy
;
Prolactin/*secretion
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Dopamine/physiology
;
Stress/*metabolism
5.A Case of Gastritis Cystica Profunda.
Jin Do KIM ; Kwon Jo LIM ; Kyong Duk SUH ; Ju Hong LEE ; Dae Young KU ; Kyung Yoon LEE ; Yong Ki PARK ; Yong Hun SHIN ; Bok Kyoo KAM ; Yong Jin KIM ; Geun Am SONG
Korean Journal of Gastrointestinal Endoscopy 1998;18(3):353-358
Gastritis Cystica Profunda is a rare condition showing multiple small cysts in the mucosa and submucosa of the stomach. These lesions have been found not only at the site of a gastroenterostomy but also in tbe stomchs of patients without any previous surgery. Recently, We witnessed a 56-year old e wale gastritis cystica profunda who had not undergone previous gastric surgery. The UGI and EGD revealed a 3.0 * 4.5 cm sized submucosal mass on the posterior wall of the antrum, and endoscopic ultrasonography(EUS) discovered a thickening of the third layer in which well-defined, round and nearly anechoic areas with posterior enhancement were gathered. They were thought to be cystic lesions. We report a case of gastritis cystica profunda without having had any previous surgery, the diagnosis was made based on findings from the EUS and histologic findings through surgery.
Diagnosis
;
Gastritis*
;
Gastroenterostomy
;
Humans
;
Middle Aged
;
Mucous Membrane
;
Stomach
6.Incidence of Metabolic Syndrome and Relative Importance of Five Components as a Predictor of Metabolic Syndrome: 5-Year Follow-up Study in Korea.
Jun Hyun HWANG ; Sin KAM ; Ji Yeon SHIN ; Jong Yeon KIM ; Kyung Eun LEE ; Gi Hong KWON ; Byung Yeol CHUN ; Shung Chull CHAE ; Dong Heon YANG ; Hun Sik PARK ; Tae Yoon HWANG
Journal of Korean Medical Science 2013;28(12):1768-1773
The aim of this study was to describe the incidence of metabolic syndrome and to identify five components as metabolic syndrome predictors. The final study included 1,095 subjects enrolled in a rural part of Daegu Metropolitan City, Korea for a cohort study in 2003. Of these, 762 (69.6%) subjects had participated in the repeat survey. During the five-year follow-up, incidence density was significantly higher for women than for men (men, 30.0/1,000 person-years; women, 46.4/1,000 person-years). In both men and women, incidence of metabolic syndrome showed a significant increase with increasing number of metabolic syndrome components at baseline. Compared with individuals presenting none of components at baseline, relative risks were increased 1.22 (men; 95% CI, 0.43-3.51), 2.21 (women; 95% CI, 0.98-4.97) times more for individuals with one component of metabolic syndrome and 5.30 (men; 95% CI, 2.31-12.13), 5.53 (women; 95% CI, 2.78-11.01) times more for those who had two components. In multivariate analysis, the most powerful risk factor for metabolic syndrome was abdominal obesity in men and low HDL-cholesterol in women (adjusted relative risk, 3.28, 2.53, respectively). Consequently, finding a high risk group for metabolic syndrome according to gender and prevention of metabolic syndrome through lifestyle modification are essential.
Adult
;
Aged
;
Cholesterol, HDL/blood
;
Cohort Studies
;
Diabetes Mellitus, Type 2/complications
;
Female
;
Follow-Up Studies
;
Humans
;
Hypertension/complications
;
Hypertriglyceridemia/complications
;
Incidence
;
Male
;
Metabolic Syndrome X/complications/*epidemiology
;
Middle Aged
;
Multivariate Analysis
;
Obesity, Abdominal/complications
;
Republic of Korea/epidemiology
;
Risk Factors
7.The Correlation between Body Mass Index and Routine Parameters in Men Over Fifty.
Deok Ha SEO ; Sol YOON ; Jae Hwi CHOI ; Jungmo DO ; Sin Woo LEE ; Chunwoo LEE ; Seong Uk JEH ; See Min CHOI ; Sung Chul KAM ; Jeong Seok HWA ; Ky Hyun CHUNG ; Sung Won KWON ; Sae Chul KIM ; Dong Soo PARK ; Jae Mann SONG ; Kyung Seop LEE ; Jae Seog HYUN
The World Journal of Men's Health 2017;35(3):178-185
PURPOSE: This study aimed to investigate the relationships between body mass index (BMI) and prostate-specific antigen (PSA) levels, international prostate symptom score (IPSS), quality of life (QoL), and prostate volume (PV). MATERIALS AND METHODS: Height, weight, PSA levels, PV, and IPSS were analyzed in 15,435 patients who underwent a prostate examination between 2001 and 2014. Patients aged <50 years or with a PSA level ≥10 ng/mL were excluded. The relationships between BMI and PSA, IPSS, QoL, and PV were analyzed by a scatter plot, one-way analysis of variance, and the Pearson correlation coefficient. RESULTS: The mean age was 71.95±7.63 years, the mean BMI was 23.59±3.08 kg/m2, the mean PSA level was 1.45±1.45 ng/mL, the mean IPSS was 15.53±8.31, the mean QoL score was 3.48±1.25, and the mean PV was 29.72±14.02 mL. PSA, IPSS, and QoL showed a tendency to decrease with increasing BMI, and there were statistically significant differences for each parameter (p≤0.001). PV showed a significant tendency to increase with BMI (p < 0.001). In the correlation analysis, BMI showed a statistically significant correlation (p < 0.001) with PSA, IPSS, and QoL, although the correlations were very weak. In contrast, BMI showed a significant correlation with PV (p < 0.001), with a meaningful Pearson correlation coefficient of 0.124. CONCLUSIONS: Higher BMI was associated with lower PSA levels and higher IPSS and QoL scores. Meanwhile, PV increased with BMI. Although obese individuals had a greater PV, obesity did not aggravate lower urinary tract symptoms.
Body Mass Index*
;
Humans
;
Lower Urinary Tract Symptoms
;
Male
;
Obesity
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Hyperplasia
;
Quality of Life